Suppr超能文献

远程自我管理认知测量与阿尔茨海默病影像学生物标志物的持续关联。

Continuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer's Disease.

机构信息

Nikki H. Stricker, Ph.D., ABPP-CN, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; 507-284-2649 (phone), 507-284-4158 (fax),

出版信息

J Prev Alzheimers Dis. 2024;11(5):1467-1479. doi: 10.14283/jpad.2024.99.

Abstract

BACKGROUND

Easily accessible and self-administered cognitive assessments that can aid early detection for Alzheimer's disease (AD) dementia risk are critical for timely intervention.

OBJECTIVES/DESIGN: This cross-sectional study investigated continuous associations between Mayo Test Drive (MTD) - a remote, self-administered, multi-device compatible, web-based cognitive assessment - and AD-related imaging biomarkers.

PARTICIPANTS/SETTING: 684 adults from the Mayo Clinic Study of Aging and Mayo Clinic Alzheimer's Disease Research Center participated (age=70.4±11.2, 49.7% female). Participants were predominantly cognitively unimpaired (CU; 94.0%).

MEASUREMENTS

Participants completed (1) brain amyloid and tau PET scans and MRI scans for hippocampal volume (HV) and white matter hyperintensities (WMH); (2) MTD remotely, consisting of the Stricker Learning Span and Symbols Test which combine into an MTD composite; and (3) in-person neuropsychological assessment including measures to obtain Mayo Preclinical Alzheimer's disease Cognitive Composite (Mayo-PACC) and Global-z. Multiple regressions adjusted for age, sex, and education queried associations between imaging biomarkers and scores from remote and in-person cognitive measures.

RESULTS

Lower performances on MTD were associated with greater amyloid, entorhinal tau, and global tau PET burden, lower HV, and higher WMH. Mayo-PACC and Global-z were associated with all imaging biomarkers except global tau PET burden. MCI/Dementia participants showed lower performance on all MTD measures compared to CU with large effect sizes (Hedge's g's=1.65-2.02), with similar findings for CU versus MCI only (Hedge's g's=1.46-1.83).

CONCLUSION

MTD is associated with continuous measures of AD-related imaging biomarkers, demonstrating ability to detect subtle cognitive change using a brief, remote assessment in predominantly CU individuals and criterion validity for MTD.

摘要

背景

便于获取且可自我管理的认知评估,有助于阿尔茨海默病(AD)痴呆风险的早期检测,对于及时干预至关重要。

目的/设计:本横断面研究调查了 Mayo Test Drive(MTD)-一种远程、自我管理、多设备兼容、基于网络的认知评估-与 AD 相关的影像学生物标志物之间的连续关联。

参与者/设置:684 名来自 Mayo 诊所衰老研究和 Mayo 诊所阿尔茨海默病研究中心的成年人参与了研究(年龄=70.4±11.2,49.7%为女性)。参与者主要认知正常(CU;94.0%)。

测量

参与者完成了(1)脑淀粉样蛋白和 tau PET 扫描以及 MRI 扫描,用于测量海马体积(HV)和白质高信号(WMH);(2)远程进行 MTD,包括 Stricker 学习跨度和符号测试,两者结合形成 MTD 综合得分;(3)进行了现场神经心理学评估,包括获得 Mayo 临床前阿尔茨海默病认知综合评分(Mayo-PACC)和全球 z 评分的测量。多元回归调整了年龄、性别和教育,以查询影像学生物标志物与远程和现场认知测量得分之间的关联。

结果

MTD 表现较低与淀粉样蛋白、内嗅皮质 tau 和总 tau PET 负担增加、HV 降低和 WMH 升高有关。Mayo-PACC 和全球 z 与除总 tau PET 负担外的所有影像学生物标志物相关。与 CU 相比,MCI/D 患者在所有 MTD 测量中的表现均较低,且效应量较大(Hedge's g's=1.65-2.02),而 CU 与 MCI 之间的差异相似(Hedge's g's=1.46-1.83)。

结论

MTD 与 AD 相关的影像学生物标志物的连续测量相关,表明使用简短的远程评估在主要 CU 个体中检测细微认知变化的能力,以及 MTD 的标准有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36e1/11436415/d94f44b9af84/42414_2024_99_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验